Just published: This work supports the favorable targeting, compartmentalizatio…
[ad_1]
Just published: This work supports the favorable targeting, compartmentalization and durability of the first FDA-approved #suprachoroidal therapy…#eyes #retina #xipere #uveitis https://t.co/LQ0o7aZkmS
[ad_2]
Source by Thomas Ciulla, MD, MBA